FDA approves tests for detecting virus in pregnant women
This article was originally published in Clinica
Executive Summary
The US FDA has approved the first two tests for detecting parvovirus B19 infection in women suspected of exposure to the virus and for the diagnosis of Fifth disease, a common childhood illness characterised by "slapped cheek" rash.
You may also be interested in...
AAM Criticizes Lower Health Care Costs Act
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
USCMA Revision Worsens Innovator Woes In Canada
A Steady Year For The Top Tier In Pharma Ahead Of Major Upheaval
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: